Equality in Medicare and Medicaid Treatment Act of 2020
A BILL
To amend title XI of the Social Security Act to improve access to care for all Medicare and Medicaid beneficiaries through models tested under the Center for Medicare and Medicaid Innovation, and for other purposes.
Sec. 2 Improving access to care for Medicare and Medicaid beneficiaries
“(ix) Whether the model will affect access to care from providers and suppliers caring for high risk patients or operating in underserved areas.
“(x) Whether the model has the potential to produce reductions in minority and rural health disparities.”
“(D) Social determinants of health payment model
“(i) In general—The social determinants of health payment model described in this subparagraph is a payment model that tests each of the payment and service delivery innovations described in clause (ii) in a region determined appropriate by the Secretary.
“(ii) Payment and service delivery innovations described—For purposes of clause (i), the payment and service delivery innovations described in this clause are the following:
“(I) Payment and service delivery innovations for behavioral health services, focusing on gathering actionable data to address the higher costs associated with beneficiaries with diagnosed behavioral conditions.
“(II) Payment and service delivery innovations targeting conditions or comorbidities of individuals entitled or enrolled under the Medicare program under title XVIII and enrolled under a State plan under the Medicaid program under title XIX to increase capacity in underserved areas.
“(III) Payment and service delivery innovations targeted on Medicaid-eligible pregnant and postpartum women, up to one year after delivery.”
“(iii) the extent to which the model improves access to care or the extent to which the model improves care for high risk patients, patients from racial or ethnic minorities, or patients in underserved areas.”
“(3) the Office of Minority Health of the Centers for Medicare & Medicaid Services certifies that such expansion will not reduce access to care for low-income, minority, or rural beneficiaries; and”
“(1) The extent and severity of minority and rural health disparities in Medicare and Medicaid beneficiaries.
“(2) The interventions that address social determinants of health in payment models selected by the Center for Medicare and Medicaid Innovation for testing.
“(3) The interventions that address social determinants of health in payment models not selected by the Center for Medicare and Medicaid Innovation for testing.
“(4) The effectiveness of interventions in mitigating negative health outcomes and higher costs associated with social determinants of health within models selected by the Center for Medicare and Medicaid Innovation for testing.
“(5) Changes in disparities among minorities and Medicare and Medicaid beneficiaries in underserved areas that are attributable to provider and supplier participation in a Phase II model.
“(6) In consultation with the Comptroller General of the United States, estimated Federal savings achieved through the reduction of rural and minority health disparities.
“(7) Other areas determined appropriate by the Secretary.”